language_icon
EN
HI

Nephrocare Health Services Share price

NEPHROPLUS

660.45

23.85 (3.75%)
NSE
BSE
Last updated on 2 Jun, 2026 | 15:50 IST
Today's High

664.00

Today's Low

624.25

52 Week Low

446.00

52 Week High

664.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Nephrocare Health Services Chart

Nephrocare Health Services Share Key Metrics

Volume
2.66 L
Market Cap
6627.00 CR
LTQ@LTP
24@660.45
ATP
646.87
Var Margin
15.55 %
Circuit Range
509.3-763.9
Delivery %
41.83 %
Value
17.19 CR
ASM/GSM
No
Market Lot
1

Summary

Nephrocare Health Services share price is ₹660.45 as of 2 Jun, 2026. The stock Nephrocare Health Services intraday movement has stayed between ₹624.25 and ₹664.00, while on a 52-week basis,Nephrocare Health Services price 52 week high is ₹664.00 & its 52 week low is ₹446.00.
In terms of trading activity, Nephrocare Health Services has recorded a volume of 265755 shares, The Nephrocare Health Services has a market cap of ₹100340717 CR. The stock’s Average Traded Price (ATP) stands at ₹646.87, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 24 @ ₹660.45.
Nephrocare Health Services operates within a circuit range of ₹509.30 – ₹763.90, with a Value of ₹17.19 CR. The Delivery Percentage for the day is 41.83%. Additionally, Nephrocare Health Services currently falls under the No framework, and trades with a market lot size of 1.

Nephrocare Health Services Fundamentals

View More
P/E Ratio

83.13

P/B Ratio

5.72

Div. Yield

0

Sector P/E

55.05

Sector P/B

-15.49

Sec. Div. Yield

0.18

Nephrocare Health Services Resistance and Support

Pivot 628.43

Resistance

First Resistance

658.16

Second Resistance

679.73

Third Resistance

709.46

Support

First Support

606.86

Second Support

577.13

Third Support

555.56

Nephrocare Health Services Shareholding Pattern

View More
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

63.85%

Mutual Fund

3.17%

Insurance

1.5%

Foreign Institutional Investors

9.94%

Domestic Institutional Investors

3.98%

Retail

17.56%

Others

0%

Total Promoters
MAR '26
63.85%

Nephrocare Health Services Corporate Actions

DateAgenda
2026-05-19Audited Results
2026-02-10Quarterly Results

Nephrocare Health Services News

Nephrocare Health Services Ltd - 544647 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Nephrocare Health Services will participate in an analyst/institutional investor meeting hosted by Bank of America on June 04, 2026. This interaction is part of the BOFA Healthcare Tour and will take place in Hyderabad. No UPSI will be discussed.
May 27 2026 16:33:25

Nephrocare Health Services Ltd - 544647 - Announcement under Regulation 30 (LODR)-Acquisition

Nephrocare Health Services has incorporated NPHSK LLP, a new step-down wholly-owned subsidiary in Kazakhstan. This strategic move aims to expand the company's kidney care and dialysis services network in the region.
May 26 2026 22:14:35

Nephrocare Health Services Ltd - 544647 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Nephrocare Health Services will participate in the HSBC Singapore Conference in Mumbai on June 18-19, 2026. The company will hold group and one-on-one meetings with investors, discussing publicly available information.
May 26 2026 20:27:43

Nephrocare Health Services Ltd - 544647 - Re-Appointment Of Internal Auditor

Nephrocare Health board convened on May 19, 2026, approving its FY26 audited standalone and consolidated financial results. The board also sanctioned a Rs.10 crore investment in its Nepal subsidiary and granted in-principal approval for Rs.140 crore in collateral support across its Singapore and Saudi Arabia subsidiaries to facilitate credit facilities.
May 19 2026 19:13:35

Nephrocare Health Services Ltd - 544647 - Issuance Of Corporate Guarantee

Nephrocare Health Services board approved collateral/security support totaling Rs. 140 crore for its Singapore and Saudi Arabia subsidiaries. This support will enable the subsidiaries to avail credit facilities from overseas banks, facilitating their business operations and working capital needs.
May 19 2026 19:07:36

Nephrocare Health Services Ltd - 544647 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Nephrocare Health Services reported strong Q4 FY26 results with revenue up 21.2% YoY to Rs.265.6 crore and net profit increasing by 27.4% YoY to Rs.35.1 crore, driven by higher treatment volumes. Full-year FY26 revenue grew 32.2% to Rs.998.8 crore.
May 19 2026 18:44:32

Nephrocare Health Services Ltd - 544647 - Board Meeting Outcome for Outcome Of The Board Meeting Held On May 19, 2026

Nephrocare Health Services' board approved audited FY26 cons. financial results, reporting ₹9,988.45 mn revenue and ₹768.40 mn net profit. The board also approved a ₹10 cr investment in its Nepal subsidiary for operations and ₹140 cr collateral support for its Singapore and Saudi Arabia units to secure credit facilities.
May 19 2026 17:53:13

Nephrocare Health Services Ltd - 544647 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

The Board of Directors of Nephrocare Health Services took on record the Monitoring Agency Report for IPO proceeds utilization for the quarter ended March 31, 2026. The report highlights Rs.177.75 crore of unutilized IPO proceeds and a delay in capital expenditure for establishing new dialysis clinics.
May 14 2026 17:33:59

Nephrocare Health Services Limited

Nephrocare Health Services board will meet on May 19, 2026, to consider and approve its audited standalone and consolidated financial results for the year ended March 2026. This meeting is for the full fiscal year.
May 04 2026 14:56:01

Nephrocare Health Services Ltd - 544647 - Board Meeting Intimation for Intimation Of Board Meeting For Considering Audited Financial Results Of The Company.

Nephrocare Health's Board is scheduled to meet on May 19, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.
May 04 2026 14:54:53
Read More

Nephrocare Health Services Management

NamePosition
Vikram VuppalaChairman & Managing Director
Vishal Vijay GuptaNominee Director of BVP Trust
View More

Nephrocare Health Services FAQs

The Buying Price of Nephrocare Health Services share is 660.45 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Nephrocare Health Services stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Nephrocare Health Services, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Nephrocare Health Services shares is 83.13. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Nephrocare Health Services shares is 5.72. Useful to assess the stock's value relative to its book value.

To assess Nephrocare Health Services’s valuation compare Sector P/E, P/B which are 55.05 & -15.49 with sector averages, along with growth rates and financial metrics.

The Market Cap of Nephrocare Health Services is 6627.00 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Nephrocare Health Services share price is 664.00 & 446.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Nephrocare Health Services belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost